Literature DB >> 22791269

A patients' and caregivers' perspective on hepatic encephalopathy.

S Montagnese1, E Amato, S Schiff, S Facchini, P Angeli, A Gatta, P Amodio.   

Abstract

Awareness of previous hepatic encephalopathy (HE) and compliance with treatment can probably reduce HE recurrence. The aim of this study was to assess the degree of awareness of previous HE and its treatment in a group of cirrhotic patients and their caregivers. Thirty-five cirrhotic patients with a history of HE and their caregivers (n = 31) were enrolled. Patients underwent evaluation of HE (clinical, psychometry and electroencephalography), quality of life (SF36 questionnaire), and awareness of HE/treatment on an ad hoc questionnaire (QAE). Caregivers underwent the QAE plus the Caregiver Burden Inventory. On the day of study, 7 patients were unimpaired, 8 had minimal and 20 low-grade overt HE. Of the patients, 37 % were aware of previous HE, 6 % of being on treatment and 6 % understood treatment effects. Of the caregivers, 48 % were aware of previous HE, 6 % of their relative being on treatment and 6 % understood treatment effects. Significant correlations were observed between neuropsychiatric status/linear HE indices and both the patients' quality of life and the caregivers' burden. In conclusion, HE awareness was poor in both patients and caregivers, most likely in relation to insufficient/inadequate provision of information.

Entities:  

Mesh:

Year:  2012        PMID: 22791269     DOI: 10.1007/s11011-012-9325-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  14 in total

1.  Spectral versus visual EEG analysis in mild hepatic encephalopathy.

Authors:  P Amodio; P Marchetti; F Del Piccolo; M de Tourtchaninoff; P Varghese; C Zuliani; G Campo; A Gatta; J M Guérit
Journal:  Clin Neurophysiol       Date:  1999-08       Impact factor: 3.708

Review 2.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

3.  Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.

Authors:  Sara Montagnese; Anna Biancardi; Sami Schiff; Paolo Carraro; Vincenzo Carlà; Guido Mannaioni; Flavio Moroni; Natascia Tono; Paolo Angeli; Angelo Gatta; Piero Amodio
Journal:  Hepatology       Date:  2011-01-03       Impact factor: 17.425

4.  Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

Authors:  Piero Amodio; Francesca Campagna; Stefania Olianas; Pamela Iannizzi; Daniela Mapelli; Marco Penzo; Paolo Angeli; Angelo Gatta
Journal:  J Hepatol       Date:  2008-06-02       Impact factor: 25.083

5.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

6.  Application of a multidimensional caregiver burden inventory.

Authors:  M Novak; C Guest
Journal:  Gerontologist       Date:  1989-12

7.  High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.

Authors:  Oliviero Riggio; Cesare Efrati; Carlo Catalano; Federica Pediconi; Oriano Mecarelli; Neri Accornero; Francesca Nicolao; Stefania Angeloni; Andrea Masini; Lorenzo Ridola; Adolfo F Attili; Manuela Merli
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

8.  Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Federica Moscucci; Manuela Merli
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-15       Impact factor: 11.382

9.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

10.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  9 in total

Review 1.  Where are we going? Translational research in hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Kevin Mullen; James G Orr; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2015-09-09       Impact factor: 3.584

Review 2.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

Review 3.  Palliative care in liver disease: what does good look like?

Authors:  Hazel Woodland; Ben Hudson; Karen Forbes; Anne McCune; Mark Wright
Journal:  Frontline Gastroenterol       Date:  2019-09-10

4.  Factors Affecting Psychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient.

Authors:  Deepa Shrestha; Sahaj Rathi; Sandeep Grover; Sunil Taneja; Ajay Duseja; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2019-06-19

Review 5.  Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy.

Authors:  Sammy Saab
Journal:  Int J Gen Med       Date:  2015-05-05

6.  An educational tool for the prophylaxis of hepatic encephalopathy.

Authors:  Maria Garrido; Matteo Turco; Chiara Formentin; Michela Corrias; Michele De Rui; Sara Montagnese; Piero Amodio
Journal:  BMJ Open Gastroenterol       Date:  2017-09-11

7.  Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis.

Authors:  Marcus-Alexander Wörns; Christian Labenz; Michael Nagel; Vanessa Weidner; Sina Schulz; Jens U Marquardt; Peter R Galle; Jörn M Schattenberg; Marc Nguyen-Tat
Journal:  Health Qual Life Outcomes       Date:  2022-02-08       Impact factor: 3.186

8.  Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Pierluigi Allosio; Maria Francesca Amendola; Sarino Aricò; Aniello Baselice; Patrizia Balbinot; Vito Campanile; Tiziana Fanucchi; Giovanni Greco; Livia Macciò; Cristina Meneguzzi; Davide Mioni; Vincenzo Ostilio Palmieri; Michele Parisi; Doda Renzetti; Raffaella Rossin; Claudia Gandin; Luigi Carlo Bottaro; Mauro Bernardi; Giovanni Addolorato; Lisa Lungaro; Giorgio Zoli; Emanuele Scafato; Fabio Caputo
Journal:  Dig Dis Sci       Date:  2021-06-17       Impact factor: 3.487

Review 9.  Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Authors:  Sara Montagnese; Jasmohan S Bajaj
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.